Malignant ureteral obstruction is an unfortunate finding that can be caused by a wide‐ranging number of malignancies with a prognosis of limited survival. Given its presentation and progression, it can be refractory to treatment by traditional single polymeric ureteral stents. With a higher failure rate than causes of benign ureteral obstruction, a number of other options are available for initial management, as well as in cases of first‐line therapy failure, including tandem stents, metallic stents, percutaneous nephrostomies and extra‐anatomic stents. We reviewed the literature and carried out a PubMed search including the following keywords and phrases: “malignant ureteral obstruction,” “tandem ureteral stents,” “metallic ureteral stents,” “resonance stent,” “metal mesh ureteral stents” and “extra‐anatomic stents.” The vast majority of studies were small and retrospective, with a large number of studies related to metallic stents. Given the heterogenous patient population and diversity of practice, it is difficult to truly assess the efficacy of each method. As there are no guidelines or major head‐to‐head prospective trials involving these techniques, it makes practicing up to the specific provider. However, this article attempts to provide a framework with which the urologist who is presented with malignant ureteral obstruction can plan in order to provide the individualized care on a case‐by‐case basis. What is clear is that prospective, randomized clinical trials are necessary to help bring evidence‐based medicine and guidelines for patients with malignant ureteral obstruction.

Objective: To expand the diagnostic armamentarium for medullary sponge kidney (MSK), we evaluate the use of high-resolution multidetector computed tomography (MDCT) for MSK diagnosis and compare to the standard intravenous urography (IVU). Despite a significant prevalence amongst stone formers, diagnosis of this well described condition has declined. IVU, the gold standard in MSK diagnosis, has largely been replaced by CT, which has previously been shown unable to demonstrate signs of MSK. Methods and Materials: Patients with known history of MSK based on IVU underwent limited MDCT urogram. Control group patients, without MSK, also had MDCT urograms performed for other clinically indicated conditions. Studies were scored by board-certified radiologists on a 0-2 scale based on the likelihood of MSK. IVU studies, when available, were similarly graded. Results: MDCT was diagnostic of MSK in 9 out of the 10 patients with known history of MSK. No false positives were present in our series. The one case of MSK not detected on MDCT was graded as a “1” on its respective IVU. Sensitivity and specificity were 90 and 100%, respectively, when compared with IVU. Conclusion: Concordance with IVU findings, despite a small reduction in sensitivity, indicates MDCT to be a suitable, and more readily available replacement for IVU in the diagnosis of MSK.

Objective: To create a protocol for providing real time operating room cost feedback to surgeons.We hypothesize that this protocol will reduce costs in a responsible way without sacrificing quality of care.Methods: All operating room costs were obtained and recorded for robotic partial nephrectomy and laparoscopic donor nephrectomy. Prior to the beginning of this project, costs pertaining to the 20 most recent cases were analyzed. Items were identified from previous cases as modifiable for replacement or omission. Timely feedback of total OR costs and cost of each item used was provided to the surgeon after each case and costs were analyzed.

Mixed flora in urine cultures usually occur due to preanalytic contamination. In our outpatient urology clinic, we detected a high prevalence of mixed flora (46.2%), which was associated with female sex and older age. Patient education did not influence the rate of mixed flora. Future efforts should target high-risk patients.